Efficacy of heterologous boosting against SARS-CoV-2 using a recombinant interferon-armed fusion protein vaccine (V-01): a randomized, double-blind and placebo-controlled phase III...

por Wang, Xuan-Yi, Mahmood, Syed Faisal, Jin, Fang, Cheah, Wee Kooi, Ahmad, Muhammad, Sohail, Mian Amjad, Ahmad, Waheed, Suppan, Vijaya K., Sayeed, Muneeba Ahsan, Luxmi, Shobha, Teo, Aik-Howe, Lee, Li Yuan, Qi, Yang-Yang, Pei, Rong-Juan, Deng, Wei, Xu, Zhong-Hui, Yang, Jia-Ming, Zhang, Yan, Guan, Wu-Xiang, Yu, Xiong
Publicado 2022